TY - JOUR
T1 - Activation of the GLP-1 receptor by a non-peptidic agonist
AU - Zhao, Peishen
AU - Liang, Yi Lynn
AU - Belousoff, Matthew J.
AU - Deganutti, Giuseppe
AU - Fletcher, Madeleine M.
AU - Willard, Francis S.
AU - Bell, Michael G.
AU - Christe, Michael E.
AU - Sloop, Kyle W.
AU - Inoue, Asuka
AU - Truong, Tin T.
AU - Clydesdale, Lachlan
AU - Furness, Sebastian G.B.
AU - Christopoulos, Arthur
AU - Wang, Ming Wei
AU - Miller, Laurence J.
AU - Reynolds, Christopher A.
AU - Danev, Radostin
AU - Sexton, Patrick M.
AU - Wootten, Denise
N1 - Funding Information:
Acknowledgements The work was supported by the Monash University Ramaciotti Centre for Cryo-Electron Microscopy, the Monash MASSIVE high-performance computing facility, the National Health and Medical Research Council of Australia (NHMRC) project grants (1061044, 1065410, 1120919 and 1126857) and NHMRC program grants (1055134 and 1150083), the Japan Society for the Promotion of Science (JSPS) KAKENHI no. 18H06043 and Japan Science and Technology Agency (JST) PRESTO no. 18069571 (to R.D.). P.M.S. and A.C. are NHMRC Senior Principal Research Fellows and D.W. is an NHMRC Senior Research Fellow. S.G.B.F. is an ARC Future Fellow. A.I. was funded by the PRIME JP17gm5910013 and the LEAP JP17gm0010004 from the Japan Agency for Medical Research and Development, and JSPS KAKENHI 17K08264. We are grateful to G. Christopoulos, V. Julita, T. Fields, C. Lafuente, J. M. Minguez, G. C. Sanz and F. Qu for assay and technical support.
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2020/1/16
Y1 - 2020/1/16
N2 - Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity1. Structures of active receptors reveal peptide agonists engage deep within the receptor core, leading to an outward movement of extracellular loop 3 and the tops of transmembrane helices 6 and 7, an inward movement of transmembrane helix 1, reorganization of extracellular loop 2 and outward movement of the intracellular side of transmembrane helix 6, resulting in G-protein interaction and activation2–6. Here we solved the structure of a non-peptide agonist, TT-OAD2, bound to the glucagon-like peptide-1 (GLP-1) receptor. Our structure identified an unpredicted non-peptide agonist-binding pocket in which reorganization of extracellular loop 3 and transmembrane helices 6 and 7 manifests independently of direct ligand interaction within the deep transmembrane domain pocket. TT-OAD2 exhibits biased agonism, and kinetics of G-protein activation and signalling that are distinct from peptide agonists. Within the structure, TT-OAD2 protrudes beyond the receptor core to interact with the lipid or detergent, providing an explanation for the distinct activation kinetics that may contribute to the clinical efficacy of this compound series. This work alters our understanding of the events that drive the activation of class B receptors.
AB - Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity1. Structures of active receptors reveal peptide agonists engage deep within the receptor core, leading to an outward movement of extracellular loop 3 and the tops of transmembrane helices 6 and 7, an inward movement of transmembrane helix 1, reorganization of extracellular loop 2 and outward movement of the intracellular side of transmembrane helix 6, resulting in G-protein interaction and activation2–6. Here we solved the structure of a non-peptide agonist, TT-OAD2, bound to the glucagon-like peptide-1 (GLP-1) receptor. Our structure identified an unpredicted non-peptide agonist-binding pocket in which reorganization of extracellular loop 3 and transmembrane helices 6 and 7 manifests independently of direct ligand interaction within the deep transmembrane domain pocket. TT-OAD2 exhibits biased agonism, and kinetics of G-protein activation and signalling that are distinct from peptide agonists. Within the structure, TT-OAD2 protrudes beyond the receptor core to interact with the lipid or detergent, providing an explanation for the distinct activation kinetics that may contribute to the clinical efficacy of this compound series. This work alters our understanding of the events that drive the activation of class B receptors.
UR - http://www.scopus.com/inward/record.url?scp=85077614219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077614219&partnerID=8YFLogxK
U2 - 10.1038/s41586-019-1902-z
DO - 10.1038/s41586-019-1902-z
M3 - Article
C2 - 31915381
AN - SCOPUS:85077614219
SN - 0028-0836
VL - 577
SP - 432
EP - 436
JO - Nature
JF - Nature
IS - 7790
ER -